Ginkgo Bioworks Holdings Inc (NYSE:DNA) has a beta value of 1.47 and has seen 71.18 million shares traded in the last trading session. The company,
During the last session, Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s traded shares were 45.52 million, with the beta value of the company hitting 1.44. At the
In the last trading session, 38.82 million shares of the Ginkgo Bioworks Holdings Inc (NYSE:DNA) were traded, and its beta was 1.41. Most recently the
Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s traded shares stood at 43.71 million during the last session, with the company’s beta value hitting 1.41. At the close
In the latest trading session,, 20.87 million Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares changed hands as the company’s beta touched 1.37. With the company’s most
In last trading session, Ginkgo Bioworks Holdings Inc (NYSE:DNA) saw 15.65 million shares changing hands with its beta currently measuring 1.35. Company’s recent per share
Ginkgo Bioworks Holdings Inc (NYSE:DNA) has a beta value of 1.36 and has seen 4.42 million shares traded in the recent trading session. The company,
During the recent session, Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s traded shares were 5.85 million, with the beta value of the company hitting 1.36. At the
In the last trading session, 27.06 million shares of the Ginkgo Bioworks Holdings Inc (NYSE:DNA) were traded, and its beta was 1.36. Most recently the
Ginkgo Bioworks Holdings Inc (NYSE:DNA)’s traded shares stood at 26.05 million during the last session, with the company’s beta value hitting 1.35. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
